353 related articles for article (PubMed ID: 21109317)
1. Angiographic patterns of restenosis after percutaneous intervention of chronic total occlusive lesions with drug-eluting stents.
Lee SP; Shin DH; Park KW; Kang HJ; Koo BK; Cho YS; Yeon TJ; Chae IH; Choi DJ; Kim HS
Int J Cardiol; 2012 Apr; 156(2):180-5. PubMed ID: 21109317
[TBL] [Abstract][Full Text] [Related]
2. Intravascular Ultrasound and Angiographic Predictors of In-Stent Restenosis of Chronic Total Occlusion Lesions.
Kang J; Cho YS; Kim SW; Park JJ; Yoon YE; Oh IY; Yoon CH; Suh JW; Youn TJ; Chae IH; Choi DJ
PLoS One; 2015; 10(10):e0140421. PubMed ID: 26465755
[TBL] [Abstract][Full Text] [Related]
3. Impact of coronary collateral circulation on angiographic in-stent restenosis in patients with stable coronary artery disease and chronic total occlusion.
Yang ZK; Shen Y; Hu J; Zhang Q; Ding FH; Zhang RY; Lu L; Shen WF
Int J Cardiol; 2017 Jan; 227():485-489. PubMed ID: 27836292
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes after the percutaneous treatment of drug-eluting stent restenosis.
Latib A; Mussardo M; Ielasi A; Tarsia G; Godino C; Al-Lamee R; Chieffo A; Airoldi F; Carlino M; Montorfano M; Colombo A
JACC Cardiovasc Interv; 2011 Feb; 4(2):155-64. PubMed ID: 21349453
[TBL] [Abstract][Full Text] [Related]
5. Late Restenosis After Paclitaxel-Coated Balloon Angioplasty Occurs in Patients With Drug-Eluting Stent Restenosis.
Habara S; Kadota K; Shimada T; Ohya M; Amano H; Izawa Y; Kubo S; Hyodo Y; Otsuru S; Hasegawa D; Tada T; Tanaka H; Fuku Y; Goto T; Mitsudo K
J Am Coll Cardiol; 2015 Jul; 66(1):14-22. PubMed ID: 26139053
[TBL] [Abstract][Full Text] [Related]
6. A comparison of procedural success rate and long-term clinical outcomes between in-stent restenosis chronic total occlusion and de novo chronic total occlusion using multicenter registry data.
Lee SH; Cho JY; Kim JS; Lee HJ; Yang JH; Park JH; Hong SJ; Choi RK; Choi SH; Gwon HC; Lim DS; Yu CW
Clin Res Cardiol; 2020 May; 109(5):628-637. PubMed ID: 31552494
[TBL] [Abstract][Full Text] [Related]
7. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.
Habara S; Iwabuchi M; Inoue N; Nakamura S; Asano R; Nanto S; Hayashi Y; Shiode N; Saito S; Ikari Y; Kimura T; Hosokawa J; Nakamura M; Kotani J; Kozuma K; Mitsudo K
Am Heart J; 2013 Sep; 166(3):527-33. PubMed ID: 24016503
[TBL] [Abstract][Full Text] [Related]
8. Drug-coated balloon angioplasty: predicting outcomes based on different patterns of drug-eluting stent restenosis.
Wang X; Lu W; Wang X; Pan L; Fu W; Liu Q; Han Z; Sun G; Qin X; Li R; Zheng X; Shan Y; Qiu C
Int J Cardiovasc Imaging; 2020 Feb; 36(2):171-178. PubMed ID: 31919705
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
[TBL] [Abstract][Full Text] [Related]
10. Independent predictors of in-stent restenosis after drug-eluting stent implantation for ostial right coronary artery lesions.
Watanabe Y; Takagi K; Naganuma T; Kawamoto H; Fujino Y; Ishiguro H; Tahara S; Kurita N; Hosawa K; Nakamura S; Nakamura S
Int J Cardiol; 2017 Aug; 240():108-113. PubMed ID: 28476515
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Prediction Model Construction of Drug-Coated Balloon Combined with Cutting Balloon Angioplasty in the Treatment of Drug-Eluting Stent In-Stent Restenosis.
Wu H; Yu T; Fan T; Liao W
Comput Math Methods Med; 2022; 2022():9832622. PubMed ID: 36238492
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of balloon angioplasty and repeat stenting in patients with drug-eluting in-stent restenosis.
Alfonso F; Sandoval J; Pérez-Vizcayno MJ; Cárdenas A; Gonzalo N; Jiménez-Quevedo P; Ibáñez B; Núñez-Gil I; Rivero F; Escaned J; Fernández-Ortíz A; Macaya C
Int J Cardiol; 2015 Jan; 178():213-20. PubMed ID: 25464257
[TBL] [Abstract][Full Text] [Related]
13. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
[TBL] [Abstract][Full Text] [Related]
14. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.
Takasawa Y; Iijima R; Shiba M; Nakamura M; Sugi K
J Cardiol; 2010 May; 55(3):391-6. PubMed ID: 20350511
[TBL] [Abstract][Full Text] [Related]
15. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C;
J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457
[TBL] [Abstract][Full Text] [Related]
16. Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention.
Solinas E; Dangas G; Kirtane AJ; Lansky AJ; Franklin-Bond T; Boland P; Syros G; Kim YH; Gupta A; Mintz G; Fahy M; Collins M; Kodali S; Stone GW; Moses JW; Leon MB; Mehran R
Am J Cardiol; 2008 Aug; 102(3):311-5. PubMed ID: 18638592
[TBL] [Abstract][Full Text] [Related]
17. Differences in tissue characterization of restenotic neointima between sirolimus-eluting stent and bare-metal stent: integrated backscatter intravascular ultrasound analysis for in-stent restenosis.
Ando H; Amano T; Takashima H; Harada K; Kitagawa K; Suzuki A; Kunimura A; Shimbo Y; Harada K; Yoshida T; Kato B; Uetani T; Kato M; Matsubara T; Kumagai S; Yoshikawa D; Isobe S; Ishii H; Murohara T
Eur Heart J Cardiovasc Imaging; 2013 Oct; 14(10):996-1001. PubMed ID: 23341147
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous intervention in chronic total coronary occlusions caused by in-stent restenosis: procedural results and long-term clinical outcomes in the TORO (Spanish registry of chronic TOtal occlusion secondary to an occlusive in-stent RestenOsis) multicentre registry.
de la Torre Hernandez JM; Rumoroso JR; Subinas A; Gonzalo N; Ojeda S; Pan M; Martín Yuste V; Suárez A; Hernández F; Teruel L; Moreu J; Cubero JM; Cascón JD; Vinhas H; Lozano Í; Martin Moreiras J; Pérez de Prado A; Goicolea J; Escaned J
EuroIntervention; 2017 Jun; 13(2):e219-e226. PubMed ID: 27993757
[TBL] [Abstract][Full Text] [Related]
19. Resistant in-stent restenosis in the drug eluting stent era.
Theodoropoulos K; Mennuni MG; Dangas GD; Meelu OA; Bansilal S; Baber U; Sartori S; Kovacic JC; Moreno PR; Sharma SK; Mehran R; Kini AS
Catheter Cardiovasc Interv; 2016 Nov; 88(5):777-785. PubMed ID: 27184223
[TBL] [Abstract][Full Text] [Related]
20. Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion.
Migliorini A; Moschi G; Vergara R; Parodi G; Carrabba N; Antoniucci D
Catheter Cardiovasc Interv; 2006 Mar; 67(3):344-8. PubMed ID: 16489559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
